C12N 2750/00033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2750/00033 (Use of viral protein as therapeutic agent other than vaccine) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 4
- Assignees
- 3
- Inventors
- 5
- Latest grant
- 7 Jan 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 0 |
By publication year.
Recent patents
- Fusion proteins comprising P3 of bacteriophage7 Jan 2020US 10,526,377 B2Proclara Biosciences, Inc.
- Fusion proteins comprising P3 of bacteriophage19 Feb 2019US 10,208,090 B2Proclara Biosciences, Inc.
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents27 Jun 2017US 9,688,728 B2Proclara Biosciences, Inc.
- Fusion proteins comprising p3 of bacteriophage13 Dec 2018US 2018/0354994 A1Proclara Biosciences, Inc.
- Fusion proteins comprising p3 of bacteriophage26 Oct 2017US 2017/0305975 A1Proclara Biosciences, Inc.
- Use of p3 of bacteriophage fusion proteins as amyloid binding agents31 Dec 2015US 2015/0376239 A1NeuroPhage Pharmaceuticals, Inc.
- Canine circovirus sequences and uses thereof2 Apr 2015US 2015/0093403 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents